Lawrence F. Eichenfield

Guest Editor for the following articles:

Sep
2012
Vol. 31. No. 3

Perspectives in Atopic Dermatitis-Optimizing Outcomes: Introduction

Lawrence F. Eichenfield, MD
The faculty members convened for this supplement provide up-to-date evidence that supports some long-held concepts; they also review other recently published data that challenge clinicians to reconsider long-standing ideas about the pathogenesis and treatment of AD.
MORE
Dec
2001
Vol. 20. No. 4

Tacrolimus and Pimecrolimus, Introduction

Lawrence F. Eichenfield, MD

A challenge in designing this issue of Seminars in Cutaneous Medicine and Surgery was to collect and present a state of the art assessment of our knowledge of these medications for dermatologic use, while acknowledging that our communal experience with them is still fairly limited.

MORE
Sep
2012
Vol. 31. No. 3

Atopic Dermatitis: Epidemiology and Pathogenesis Update

Amy S. Paller, MD | Anthony J. Mancini, MD | Charles N. Ellis, MD | Eric L. Simpson, MD, MCR | Lawrence F. Eichenfield, MD
Worldwide, the prevalence of atopic dermatitis (AD) has increased approximately threefold since the 1960s.
MORE
Sep
2017
Vol. 36. No. 3

Diagnosis, comorbidity, and psychosocial impact of atopic dermatitis

Andrea Waldman, MD | Dawn Marie Davis, MD | Jennifer LeBovidge, PhD | Jonathan Spergel, PhD | Jusleen Ahluwalia, MD | Megha M Tollefson, MD | Nathan Jetter, BS | Sharon E Jacob, MD
Understanding both the clinical characteristics and implications of AD is critical to lessening the psychosocial, clinical, and economic burden of this disease.
MORE
Dec
2001
Vol. 20. No. 4

Pathophysiologic Mechanisms in Atopic Dermatitis

Donald YM Leung, PhD | Mark Boguniewicz, MD

This article examines theĀ  pathophysiologic mechanisms involved in atopic dermatitis. An understanding of these mechanisms is critical for developing new treatment strategies for this increasingly common illness.

MORE